Intravenous Tissue Plasminogen Activator as Provocateur of Myocardial Infarction

被引：2
作者：
Burlen, Jordan [1 ]
Cholin, Liza [1 ]
Ruzieh, Mohammed [2 ]
Dasa, Osama [2 ]
机构：
[1] Univ Louisville, Sch Med, Dept Internal Med, Louisville, KY 40292 USA
[2] Univ Toledo, Coll Med, Dept Internal Med, 2801 W Bancroft St, Toledo, OH 43606 USA
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2017年 / 24卷 / 04期
关键词：
ISCHEMIC-STROKE; THERAPY;
D O I：
10.1097/MJT.0000000000000494
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E489 / E490
页数：2
相关论文
共 50 条
  • [21] Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients
    Satoru Takeuchi
    Kojiro Wada
    Kimihiro Nagatani
    Naoki Otani
    Hideo Osada
    Hiroshi Nawashiro
    Acta Neurochirurgica, 2012, 154 : 87 - 87
  • [22] Acute Central Retinal Artery Occlusion Treated with Intravenous Recombinant Tissue Plasminogen Activator
    Nowak, Richard J.
    Amin, Hardik
    Robeson, Kimberly
    Schindler, Joseph L.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2012, 21 (08) : 913.e5 - 913.e8
  • [23] Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator
    Bissig, David
    Manjunath, Rashmi
    Traylor, Brittany R.
    Richman, David P.
    Ng, Kwan L.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2017, 26 (06) : E102 - E104
  • [24] Does Mild Deficit for Patients with Stroke Justify the Use of Intravenous Tissue Plasminogen Activator?
    Hassan, Ameer E.
    Zacharatos, Haralabos
    Hassanzadeh, Bahareh
    El-Gengaihy, Ahmed
    AlKawi, Ammar
    Shhadeh, Akram
    Kirmani, Jawad F.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2010, 19 (02) : 116 - 120
  • [25] ROLE OF EMERGENCY TISSUE PLASMINOGEN ACTIVATOR IN ISCHEMIC STROKE
    Alhejaily, Mohammed Ahmed
    Almutairi, Majed Meshal
    Alzaidi, Ahmad Abdulghani
    Alshehri, Fahad Abdullah Ali
    Alaql, Abdulrahman Bader
    Almalki, Muhammad Abdullah M.
    Almasabi, Mohammed Ahmed
    Alhamyani, Abdulmajeed Hamed
    Abuhalimeh, Faisal Fawzi
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (01): : 2667 - 2670
  • [26] Intravenous tissue plasminogen activator for ischemic stroke in early pregnancy dosed by actual body weight
    Peksa, Gary D.
    Ostrem, Jamie
    Davis, Teresa
    SAGE OPEN MEDICAL CASE REPORTS, 2019, 7
  • [27] Rapid Neurological Recovery after Intravenous Tissue Plasminogen Activator in Stroke: Prognostic Factors and Outcome
    Machumpurath, Bejoy
    Davis, Stephen M.
    Yan, Bernard
    CEREBROVASCULAR DISEASES, 2011, 31 (03) : 278 - 283
  • [28] Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: Initial Israeli experience
    Schwammenthal, Y
    Drescher, MJ
    Merzeliak, O
    Tsabari, R
    Bruk, B
    Feibel, M
    Hoffman, C
    Bakon, M
    Rotstein, Z
    Chapman, J
    Tanne, D
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2004, 6 (02): : 70 - 74
  • [29] Utilization of Intravenous Tissue Plasminogen Activator and Reasons for Nonuse in Acute Ischemic Stroke in Saudi Arabia
    Al Khathaami, Ali M.
    Al Bdah, Bayan
    Tarawneh, Maisoun
    Alskaini, Mohammed
    Alotaibi, Faris
    Alshalan, Abdulaziz
    Almuhraj, Mohammed
    Aldaham, Daham
    Alotaibi, Nasser
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2020, 29 (05)
  • [30] Smoking-Thrombolysis Paradox Recanalization and Reperfusion Rates After Intravenous Tissue Plasminogen Activator in Smokers With Ischemic Stroke
    Kufner, Anna
    Nolte, Christian H.
    Galinovic, Ivana
    Brunecker, Peter
    Kufner, Gerald M.
    Endres, Matthias
    Fiebach, Jochen B.
    Ebinger, Martin
    STROKE, 2013, 44 (02) : 407 - 413
12345